Symbol
KTTA on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership
83.9K shares
Security Ownership
3.1%

Lawrence Steinman ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

2025-03-06 - Lawrence Steinman has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 83.9K shares of Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA). This represents 3.1% percent ownership of the company.